Editorial
doi: 10.1016/j.medj.2021.09.006.
Cell-free DNA in Hodgkin Lymphoma: A future standard?
Affiliations
- PMID: 35590203
- DOI: 10.1016/j.medj.2021.09.006
Item in Clipboard
Editorial
Cell-free DNA in Hodgkin Lymphoma: A future standard?
Med.
.
Free article
Abstract
In this issue of Med, Sobesky et al. investigate the translational utility of sequencing cell-free DNA to describe genetic features of classic Hodgkin Lymphoma (HL) and to evaluate minimal residual disease (MRD) for patients treated in a clinical trial1.
Copyright © 2021. Published by Elsevier Inc.
Conflict of interest statement
Declaration of interests T.A. declares no competing interests.
Comment on
-
In-depth cell-free DNA sequencing reveals genomic landscape of Hodgkin's lymphoma and facilitates ultrasensitive residual disease detection.Med. 2021 Oct 8;2(10):1171-1193.e11. doi: 10.1016/j.medj.2021.09.002. Med. 2021. PMID: 35590205
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
